Please ensure Javascript is enabled for purposes of website accessibility
Home / News / St. Charles Business Record / Mizzou, Santarus presses patent claims against Par

Mizzou, Santarus presses patent claims against Par

Santarus and the University of Missouri accused the generic drugmaker Par Pharmaceutical of infringing five U.S. patents for the heartburn medicine Zegerid as a nonjury trial began in federal court. Santarus, a San Diego-based company that licenses the patents from the university, sued in 2007 contending Par, of Woodcliff Lake, N.J., plans to market a copy ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*